Hera’s talk at Scientist.com on using the SRG rat for the 3Rs Hera’s talk at Scientist.com on using the SRG rat for the 3Rs Hera Admin2022-10-12T13:34:42+00:00 Read More
A Rag2/Il2rg double-knockout rat supports engraftment of human immune system for immunotherapy-based cancer efficacy studies A Rag2/Il2rg double-knockout rat supports engraftment of human immune system for immunotherapy-based cancer efficacy studies Hera Admin2022-10-12T13:34:43+00:00 Read More
The SRG™ rat: A novel SCID rat for humanization studies The SRG™ rat: A novel SCID rat for humanization studies Hera Admin2022-10-12T13:34:43+00:00 Read More
A Novel Immunodeficient Rat for Modeling Human Cancer A Novel Immunodeficient Rat for Modeling Human Cancer Hera Admin2022-10-12T13:34:43+00:00 Read More
Novel immunodeficient rat models capable of supporting the growth of human tumor xenografts Novel immunodeficient rat models capable of supporting the growth of human tumor xenografts Hera Admin2022-10-12T13:34:43+00:00 Read More
Novel immunodeficient rat models offers a unique platform for drug efficacy studies in human tumor xenografts Novel immunodeficient rat models offers a unique platform for drug efficacy studies in human tumor xenografts Hera Admin2022-10-12T13:34:43+00:00 Read More
Sprague Dawley Rag2 null rats created from engineered spermatogonial stem cells are immunodeficient and permissive to human xenografts Jack Crawford2022-10-11T12:02:20+00:00 Read More
Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts. Maulhardt et al Jack Crawford2021-03-24T17:53:42+00:00 Read More
Orally -Bioavailable Androgen Receptor Degrader, Potential Next-Generation Therapeutic for Enzalutamide-Resistant Prostate Cancer. Ponnusamy and Narayana et al Jack Crawford2021-04-05T09:15:41+00:00 Read More
